跳至主要内容
临床试验/IRCT20190916044781N1
IRCT20190916044781N1已完成未知

Effect of GnRh Agonist short acting in IVF outcome improvement in FET cycles

Sarem Fertility and Infertility Research Center0 个研究点目标入组 240 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 40 years(—)
性别
Female

入选标准

  • Have at least two embryos for transfer.
  • The embryo has been removed from the freeze after thawing and has grade A quality.
  • Absence of internal uterine anomalies such as adenomyosis and uterine fibroids and uterine malformations
  • Absence of clear endometrioma
  • Patients who used the agonist protocol in the ICSI cycle.
  • Absence of systemic diseases (such as collagen, vascular disease, chronic hypertension, diabetes: a well-known case of diabetes with a fasting FBS of over 126)
  • Vitamin D should be modified before starting ICSI.
  • Age range from 25 to 40 years.

排除标准

  • Determine endometrioma during FET.

研究者

发起方
Sarem Fertility and Infertility Research Center

相似试验